Top Markets
#1 PulseChain PulseChain +45.01%
#2 MarsCoin MarsCoin +17.39%
#3 Not in Employment, Education, or Training Not in Employment, Education, or Training +16.92%
#4 RedStone RedStone +15.11%
#5 Bitway Bitway +11.33%
#6 Meteora Meteora +9.28%
#7 Lorenzo Wrapped Bitcoin Lorenzo Wrapped Bitcoin +8.13%
#8 Lighter Lighter +8.05%
#9 SkyAI SkyAI +7.96%
#10 OPENLOOT OPENLOOT +7.58%
Coin of the day
PulseChain PulseChain
Setări
Limbă
ROMâNă
Monedă
USD
Temă
Marinus Pharmaceuticals, Inc. Marinus Pharmaceuticals, Inc.

Marinus Pharmaceuticals, Inc.

MRNS
Rang în acțiuni #28046
Marinus Pharmaceuticals, Inc. is a specialized biopharmaceutical firm dedicated... Marinus Pharmaceuticals, Inc. is a specialized biopharmaceutical firm dedicated to the development and commercialization of therapeutic solutions for individuals suffering from rare genetic epilepsies and other seizure-related conditions. The company's primary commercialized product is ZTALMY, an oral suspension specifically designed to manage seizures associated with cyclin-dependent kinase-like 5 deficiency disorder (CDD). This medication is prescribed for both adult and pediatric patient populations, suitable for use in acute and chronic care settings, and can be administered either in-patient or by the patient themselves. ZTALMY exerts its effect by targeting synaptic and extrasynaptic GABAA receptors, a mechanism that also suggests potential anticonvulsant, antidepressant, and anxiolytic benefits. Beyond ZTALMY, Marinus is actively progressing ganaxolone through development, an investigational therapy aimed at various genetic epileptic conditions such as PCDH19-related epilepsy, tuberous sclerosis complex, and Lennox-Gastaut Syndrome, with additional exploration for depressive disorders. The company maintains strategic alliances, including licensing agreements with Purdue Neuroscience Company and CyDex Pharmaceuticals, Inc., as well as a collaborative partnership with Orion Corporation. Marinus Pharmaceuticals was established in 2003 and operates from its corporate headquarters in Radnor, Pennsylvania.
Preț acțiune
$0.55
Ultima sincronizare: 2025-02-11
Capitalizare de piață
$28.90M
Schimbare (1 zi)
0.00%
Schimbare (1 an)
0.00%
Țară
US
Tranzacționează Marinus Pharmaceuticals, Inc. (MRNS)

Categorie

Healthcare
Număr de acțiuni în circulație pentru Marinus Pharmaceuticals, Inc. (MRNS)
Număr de acțiuni în circulație la data de September 2024: 57.23M
Conform celor mai recente rapoarte financiare și prețului acțiunilor Marinus Pharmaceuticals, Inc., numărul curent de acțiuni în circulație este 57.23M. La sfârșitul anului December 2022, compania avea 39.07M acțiuni în circulație. Numărul de acțiuni în circulație este de obicei influențat de splituri de acțiuni și programe de răscumpărare.
Istoricul acțiunilor în circulație pentru Marinus Pharmaceuticals, Inc. (MRNS) din 2012 până în 2026
Acțiuni în circulație la sfârșitul fiecărui an
An Acțiuni în circulație Schimbă
2026 (TTM) 57.23M 6.48%
2023 53.75M 37.56%
2022 39.07M 6.47%
2021 36.70M 34.57%
2020 27.27M 100.10%
2019 13.63M 33.30%
2018 10.22M 73.72%
2017 5.89M 20.73%
2016 4.87M 30.69%
2015 3.73M 142.49%
2014 1.54M -23.70%
2013 2.02M 0.00%
2012 2.02M 0.00%
Acțiuni în circulație pentru companii similare sau concurente
Companie Acțiuni în circulație Diferență Țara
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 253.90M 343.65%
US
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 396.00M 591.95%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 62.19M 8.66%
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 483.58M 744.98%
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH